X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (723) 723
Newspaper Article (449) 449
Publication (149) 149
Paper (139) 139
Book / eBook (87) 87
Patent (60) 60
Magazine Article (33) 33
Book Review (19) 19
Dissertation (18) 18
Book Chapter (16) 16
Conference Proceeding (8) 8
Reference (4) 4
Web Resource (4) 4
Trade Publication Article (2) 2
Government Document (1) 1
Streaming Audio (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
physics (180) 180
experiment (153) 153
particle physics (138) 138
humans (131) 131
index medicus (102) 102
high energy physics - experiment (81) 81
physics, particles & fields (74) 74
physics - high energy physics - experiment (73) 73
female (72) 72
male (67) 67
particle physics - experiment (64) 64
fysik (61) 61
physical sciences (61) 61
natural sciences (60) 60
naturvetenskap (60) 60
middle aged (56) 56
aged (53) 53
high energy physics (53) 53
research (46) 46
subatomär fysik (46) 46
adult (45) 45
subatomic physics (45) 45
e+e annihilation (42) 42
oncology (40) 40
lund monte-carlo (38) 38
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (37) 37
jet fragmentation (36) 36
phenomenology (33) 33
detector (32) 32
analysis (31) 31
cancer (31) 31
animals (30) 30
lep (28) 28
athletes (27) 27
physics of elementary particles and fields (27) 27
hadron-hadron scattering (26) 26
care and treatment (25) 25
calculating (24) 24
computing (24) 24
counting (24) 24
nuclear experiment (24) 24
aged, 80 and over (23) 23
history (23) 23
treatment outcome (23) 23
chemotherapy (22) 22
health aspects (20) 20
united kingdom (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
elementary particles, quantum field theory (19) 19
immunology (19) 19
quantum field theories, string theory (19) 19
collisions (18) 18
image data processing or generation, in general (18) 18
leptons (18) 18
monte-carlo (18) 18
radiative-corrections (18) 18
tournaments & championships (18) 18
united states (18) 18
clinical trials (17) 17
standard model (17) 17
viruses (17) 17
article (16) 16
electronic books (16) 16
human necessities (16) 16
hygiene (16) 16
medical or veterinary science (16) 16
preparations for medical, dental, or toilet purposes (16) 16
disease-free survival (15) 15
high-energies (15) 15
medicine, general & internal (15) 15
opal detector (15) 15
studies (15) 15
abridged index medicus (14) 14
antineoplastic combined chemotherapy protocols - adverse effects (14) 14
bhabha scattering (14) 14
detectors (14) 14
genetic aspects (14) 14
photon corrections (14) 14
therapy (14) 14
astronomy, astrophysics and cosmology (13) 13
colorectal cancer (13) 13
medical research (13) 13
medicine (13) 13
qcd (13) 13
risk factors (13) 13
tumors (13) 13
z0 decays (13) 13
astronomy & astrophysics (12) 12
astrophysics (12) 12
e+e-physics (12) 12
hospitals (12) 12
kaplan-meier estimate (12) 12
measurement science and instrumentation (12) 12
mutation (12) 12
nuclear energy (12) 12
nuclear physics, heavy ions, hadrons (12) 12
physics, multidisciplinary (12) 12
railroads (12) 12
coaches & managers (11) 11
decay (11) 11
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (32) 32
UTL at Downsview - May be requested (12) 12
Gerstein Science - Stacks (8) 8
UofT at Mississauga - Stacks (8) 8
UofT at Scarborough - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Music - Stacks (7) 7
Trinity College (John W Graham) - Stacks (6) 6
Victoria University E.J. Pratt - Stacks (5) 5
OISE - Stacks (4) 4
Online Resources - Online (4) 4
St. Michael's College (John M. Kelly) - 2nd Floor (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Engineering & Comp. Sci. - Stacks (2) 2
Law (Bora Laskin) - Stacks (2) 2
University College (Laidlaw) - Stacks (2) 2
Architecture Landscape (Shore + Moffat) - Stacks (1) 1
Art - Reference (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Engineering & Comp. Sci. - Special Collections (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Music - Storage2 (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Regis College - Stacks (1) 1
Robarts - May be requested in 6-10 wks (1) 1
Robarts - Reference (1) 1
Royal Ontario Museum - Periodical Stacks (1) 1
Royal Ontario Museum - Stacks (1) 1
St. Augustine's Seminary - Stacks (1) 1
St. Michael's College (John M. Kelly) - Audio Visual (1) 1
Trinity College (John W Graham) - Reference (1) 1
Victoria University CRRS - Library use only (1) 1
Victoria University E.J. Pratt - Reference (1) 1
Victoria University E.J. Pratt - Virginia Woolf (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1410) 1410
French (18) 18
German (5) 5
Chinese (4) 4
Korean (3) 3
Portuguese (2) 2
Japanese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2010, ISBN 0199580537, 2016 pages
Thomas Middleton (1580-1627) - 'our other Shakespeare' - is the only other Renaissance playwright who created lasting masterpieces of both comedy and tragedy;... 
English drama | Literature: History & Criticism | English literature | d. 1627 | 2007 | Works | Early modern, 1500-1700 | Middleton, Thomas
Book
Australian Academic & Research Libraries, ISSN 0004-8623, 03/2007, Volume 38, Issue 1, pp. 64 - 64
Journal Article
2017, First edition., ISBN 0199591164, xxxii, 741 pages
This companion volume to The New Oxford Shakespeare: The Complete Works concentrates on the issues of canon and chronology. This major work in attribution... 
Shakespeare, William, 1564-1616 Authorship | Shakespeare, William,-1564-1616-Authorship | English drama-Early modern and Elizabethan, 1500-1600-History and criticism | Shakespeare, William,-1564-1616-Authorship-Collaboration
Book
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10073, pp. 1011 - 1024
Summary Background The ESPAC-3 trial showed that adjuvant gemcitabine is the standard of care based on similar survival to and less toxicity than adjuvant... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | THERAPY | ADENOCARCINOMA | CHEMORADIOTHERAPY | FOLINIC ACID | MODEL | CHEMOTHERAPY | Capecitabine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Carcinoma, Pancreatic Ductal - surgery | Antimetabolites, Antineoplastic - administration & dosage | Pancreatic Neoplasms - drug therapy | Aged, 80 and over | Adult | Carcinoma, Pancreatic Ductal - mortality | Deoxycytidine - adverse effects | Female | Pancreatic Neoplasms - mortality | Chemotherapy, Adjuvant | Deoxycytidine - administration & dosage | Pancreatic Neoplasms - surgery | Kaplan-Meier Estimate | Treatment Outcome | Carcinoma, Pancreatic Ductal - drug therapy | Capecitabine - adverse effects | Antimetabolites, Antineoplastic - adverse effects | Aged | Deoxycytidine - analogs & derivatives | Antimitotic agents | Cancer patients | Care and treatment | Pancreatic cancer | Clinical trials | Product development | Metastasis | Comparative analysis | Antineoplastic agents | Studies | Antigens | Chemotherapy | Acids | Pragmatism | Pharmaceutical industry | Cancer therapies | Abdomen | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 481 - 489
Summary Background EGFR overexpression occurs in 27–55% of oesophagogastric adenocarcinomas, and correlates with poor prognosis. We aimed to assess addition of... 
Hematology, Oncology and Palliative Medicine | GROWTH-FACTOR RECEPTOR | 1ST-LINE TREATMENT | CETUXIMAB | PROSPECTIVE MULTICENTER | ONCOLOGY | GASTRIC-CANCER | PROGNOSTIC-SIGNIFICANCE | CELL-LINES | METASTATIC COLORECTAL-CANCER | ESOPHAGEAL ADENOCARCINOMA | III TRIAL | Multivariate Analysis | Adenocarcinoma - pathology | Capecitabine | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Stomach Neoplasms - pathology | Epirubicin - administration & dosage | Molecular Targeted Therapy | Esophageal Neoplasms - pathology | Early Termination of Clinical Trials | Organoplatinum Compounds - administration & dosage | Receptor, Epidermal Growth Factor - metabolism | Fluorouracil - administration & dosage | Time Factors | Biomarkers, Tumor - metabolism | Esophageal Neoplasms - mortality | Female | Biomarkers, Tumor - antagonists & inhibitors | Odds Ratio | Stomach Neoplasms - enzymology | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Adenocarcinoma - enzymology | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | United Kingdom | Stomach Neoplasms - drug therapy | Chi-Square Distribution | Adenocarcinoma - drug therapy | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Esophageal Neoplasms - enzymology | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Esophageal Neoplasms - drug therapy | Stomach Neoplasms - mortality | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Care and treatment | Anthracyclines | Product development | Cancer
Journal Article
2007, The Oxford Middleton., ISBN 9780198185697, 1183
Thomas Middleton and Early Modern Textual Culture is a comprehensive companion to The Collected Works of Thomas Middleton, providing detailed introductions to... 
Middleton, Thomas, -1627 Criticism and interpretation | Criticism, Textual | English literature | d. 1627 | England | Editing | History | Book industries and trade | Transmission of texts | 17th century | 16th century | Middleton, Thomas | Early modern, 1500-1700 | Manuscripts, English
Book
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 8, pp. 749 - 759
Summary Background Therapeutic antibodies targeting EGFR have activity in advanced colorectal cancer, but results from clinical trials are inconsistent and the... 
Hematology, Oncology and Palliative Medicine | PHASE-III TRIAL | COLON-CANCER | 1ST-LINE TREATMENT | LEUCOVORIN | ONCOLOGY | BEVACIZUMAB | PROSPECTIVE MOLECULAR STRATIFICATION | CETUXIMAB PLUS IRINOTECAN | OXALIPLATIN | COMBINATION | CHEMOTHERAPY | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Prospective Studies | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Fluorouracil - therapeutic use | Receptor, Epidermal Growth Factor - metabolism | Time Factors | Antineoplastic Agents - adverse effects | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Colorectal Neoplasms - enzymology | Camptothecin - therapeutic use | Drug Administration Schedule | Proportional Hazards Models | Proto-Oncogene Proteins - genetics | Treatment Outcome | United Kingdom | Chi-Square Distribution | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Drug Resistance, Neoplasm - genetics | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Mutation | Colorectal Neoplasms - pathology | Antimitotic agents | Clinical trials | Care and treatment | Antineoplastic agents | Colorectal cancer | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9779, pp. 1749 - 1759
Summary Background Elderly and frail patients with cancer, although often treated with chemotherapy, are under-represented in clinical trials. We designed... 
Internal Medicine | CAPECITABINE | 1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | LEUCOVORIN | ONCOLOGY | CLINICAL-TRIALS | OLDER | COMBINATION CHEMOTHERAPY | OXALIPLATIN | FLUOROURACIL | COIN | Adenocarcinoma - pathology | Capecitabine | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Dose-Response Relationship, Drug | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Deoxycytidine - adverse effects | Female | Colorectal Neoplasms - mortality | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Administration, Oral | Deoxycytidine - administration & dosage | United Kingdom | Frail Elderly | Adenocarcinoma - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quality of Life | Aged | Infusions, Intravenous | Colorectal Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Organoplatinum Compounds - adverse effects | Adenocarcinoma - mortality | Care and treatment | Research | Health aspects | Colorectal cancer | Clinical trials | Frailty | Chemotherapy | Drug therapy | Toxicity | elderly | survival | councils | clinical trials | colorectal carcinoma | quality of life | chemotherapy | Cancer
Journal Article